Pharmaceutical composition, processes for increasing and maintaining the homogeneity of a pharmaceutical composition and for treating, reversing, reducing or inhibiting retroviral infections, use of abacavir, lamivudine, zidovudine or a pharmaceutically acceptable derivative thereof, and a pharmaceutically acceptable gliding agent , article of manufacture, and, process for the preparation of a pharmaceutical composition

摘要

"PHARMACEUTICAL COMPOSITION, PROCESSES TO INCREASE AND MAINTAIN THE HOMOGENEITY OF A PHARMACEUTICAL COMPOSITION AND TO, TREAT, REVERSE, REDUCE OR INHIBIT RETROVIRAL INFECTIONS, USE OF ABACAVIR, LAMIVUDINE, ZIDOVUDINE OR DEALING WITH A DERIVATION OF A DERIVATION PHARMACEUTICALLY ACCEPTABLE, MANUFACTURING ARTICLE, AND PROCESS FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION "a pharmaceutical composition is exposed, which comprises a homogeneous combination of abacavir, lamivudine, and zidovudine, in an amount that achieves antiviral efficacy, a process for preparation for antiviral of such a composition, and a process for inhibiting the human immunodeficiency virus (HIV), which comprises administering such a composition to an HIV-infected patient.